Investigation of efficacy and safety of insulin degludec or insulin glargine in type 2 diabetes with basal-bolus therapy
Not Applicable
- Conditions
- type 2 diabetes
- Registration Number
- JPRN-UMIN000013872
- Lead Sponsor
- Juntendo University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
1)hypersensitivity to degludec 2)patient with hypoglycemia 3)patient with serious liver and kidney disease 4)patient with proliferative retinopathy 5)during pregnancy and lactation
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method